首页 > 最新文献

American Journal of Preventive Medicine最新文献

英文 中文
Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and Rubella. 麻疹、腮腺炎和风疹免疫球蛋白 M 检测的适宜性。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-23 DOI: 10.1016/j.amepre.2024.07.014
Thomas D Filardo, Nina B Masters, Jessica Leung, Sarah Baca, Heartley Egwuogu, Oscar Rincon Guevara, Julia Raykin, David E Sugerman

Introduction: Testing for immunity to measles, mumps, and rubella should include only immunoglobulin G (IgG); immunoglobulin M (IgM) testing is appropriate only if acute illness is suspected. The appropriateness of measles, mumps, and rubella IgM testing was evaluated in a national administrative dataset.

Methods: Laboratory testing for measles, mumps, and rubella during 2019-2022 was analyzed in 2024 using HealthVerity administrative claims and laboratory data. IgG, IgM, and reverse-transcriptase polymerase chain reaction (RT-PCR) testing are described by year, demographics, and region. IgM testing was examined for appropriateness, defined as an IgM test combined with diagnostic codes indicative of acute illness.

Results: During 2019-2022, IgM testing represented a small proportion of serologic testing (measles: 3.3%, mumps: 2.4%, rubella: 2.1%) but appeared to be appropriately performed in only 15.4% of cases for measles, 32.8% of cases for mumps, and 10.2% of cases for rubella. IgM testing was more commonly performed for female patients, with the largest discrepancy seen for rubella (90.5% female vs 9.5% male). IgM for measles and mumps was more often performed appropriately for persons aged 0-19 years (37.6% and 60.1%) compared with persons aged 20-49 years (11.8% and 22.0%) and 50+ years (16.5% and 33.8%).

Conclusions: The majority of IgM testing for measles, mumps, and rubella during this period appeared inappropriate. Clinicians and health systems could ensure that IgG testing alone is performed when evaluating for immunity through modifications to electronic medical records and commercial laboratories could ensure that providers are able to test for IgG alone when evaluating immunity.

导言:麻疹、腮腺炎和风疹免疫力检测只应包括 IgG;IgM 检测仅适用于疑似急性疾病的情况。我们在全国行政数据集中对麻疹、腮腺炎和风疹 IgM 检测的适宜性进行了评估:利用 HealthVerity 行政报销和实验室数据分析了 2024 年 2019-2022 年期间麻疹、腮腺炎和风疹的实验室检测情况。按年份、人口统计学和地区描述了 IgG、IgM 和反转录聚合酶链反应 (RT-PCR) 检测。对 IgM 检测的适当性进行了研究,IgM 检测的定义是 IgM 检测与表明急性病的诊断代码相结合:2019-2022年期间,IgM检测在血清学检测中只占一小部分(麻疹:3.3%;腮腺炎:2.4%;风疹:2.1%),但似乎只有15.4%的麻疹病例、32.8%的腮腺炎病例和10.2%的风疹病例进行了适当的IgM检测。女性患者更常进行 IgM 检测,其中风疹检测的差异最大(90.5% 为女性,9.5% 为男性)。与 20-49 岁(11.8% 和 22.0%)和 50 岁以上(16.5% 和 33.8%)的人相比,0-19 岁的人更常进行适当的麻疹和腮腺炎 IgM 检测(37.6% 和 60.1%):结论:在此期间,大多数麻疹、腮腺炎和风疹的 IgM 检测似乎并不恰当。临床医生和医疗系统可通过修改电子病历确保在评估免疫力时只进行 IgG 检测,商业实验室可确保医疗服务提供者在评估免疫力时只进行 IgG 检测。
{"title":"Appropriateness of Immunoglobulin M Testing for Measles, Mumps, and Rubella.","authors":"Thomas D Filardo, Nina B Masters, Jessica Leung, Sarah Baca, Heartley Egwuogu, Oscar Rincon Guevara, Julia Raykin, David E Sugerman","doi":"10.1016/j.amepre.2024.07.014","DOIUrl":"10.1016/j.amepre.2024.07.014","url":null,"abstract":"<p><strong>Introduction: </strong>Testing for immunity to measles, mumps, and rubella should include only immunoglobulin G (IgG); immunoglobulin M (IgM) testing is appropriate only if acute illness is suspected. The appropriateness of measles, mumps, and rubella IgM testing was evaluated in a national administrative dataset.</p><p><strong>Methods: </strong>Laboratory testing for measles, mumps, and rubella during 2019-2022 was analyzed in 2024 using HealthVerity administrative claims and laboratory data. IgG, IgM, and reverse-transcriptase polymerase chain reaction (RT-PCR) testing are described by year, demographics, and region. IgM testing was examined for appropriateness, defined as an IgM test combined with diagnostic codes indicative of acute illness.</p><p><strong>Results: </strong>During 2019-2022, IgM testing represented a small proportion of serologic testing (measles: 3.3%, mumps: 2.4%, rubella: 2.1%) but appeared to be appropriately performed in only 15.4% of cases for measles, 32.8% of cases for mumps, and 10.2% of cases for rubella. IgM testing was more commonly performed for female patients, with the largest discrepancy seen for rubella (90.5% female vs 9.5% male). IgM for measles and mumps was more often performed appropriately for persons aged 0-19 years (37.6% and 60.1%) compared with persons aged 20-49 years (11.8% and 22.0%) and 50+ years (16.5% and 33.8%).</p><p><strong>Conclusions: </strong>The majority of IgM testing for measles, mumps, and rubella during this period appeared inappropriate. Clinicians and health systems could ensure that IgG testing alone is performed when evaluating for immunity through modifications to electronic medical records and commercial laboratories could ensure that providers are able to test for IgG alone when evaluating immunity.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Physical Activity and Sitting Time Balance Index and All-Cause Mortality Risk. 体力活动和久坐时间平衡指数与全因死亡率风险。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-23 DOI: 10.1016/j.amepre.2024.07.015
Roslin Botlero, Parneet Sethi, Danijela Gasevic, Neville Owen, Elizabeth Barr, David W Dunstan

Introduction: Achieving a healthier balance of more time spent in physical activity (PA) and less time in sedentary behavior is now widely advocated for achieving multiple health benefits. This study introduces a Physical Activity and Sitting Time Balance Index (PASTBI), a potential risk identification tool addressing the interplay between PA and sedentary behavior; and aims to explore its association with the risk of all-cause mortality in Australian adults.

Methods: This prospective cohort study analyzed the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) data on 5,836 Australian adults. The PASTBI was calculated by dividing the total duration of PA (minutes/day) by the duration of sitting time (ST) (hours/day), both self-reported at baseline (2004-2005). The PASTBI was expressed in quartiles ranging from Q1 - low PA/high ST to Q4 - high PA/low ST. The association between PASTBI and all-cause mortality was explored (in 2022) using the Cox proportional hazards regression models adjusted for socio-demographics, lifestyle factors, waist circumference, and the number of comorbidities.

Results: During 78,406 person-years of follow-up (median follow-up of 14.3 years), there were 885 deaths (15%). In the fully adjusted model, compared to those in the highest PASTBI category (Quartile 4 - high PA/low ST), participants from the lowest PASTBI category (Quartile 1 - low PA/high ST) were at a higher risk of all-cause mortality [HR (95% CI) = 1.47 (1.21-1.79)].

Conclusions: A less favorable balance of time spent in PA and ST (as characterized by a parsimonious PASTBI index approach) was associated with a higher risk of all-cause mortality.

导言:目前,人们普遍提倡多花时间进行体育锻炼(PA),少花时间久坐不动,以实现更健康的平衡,从而获得多重健康益处。本研究引入了 "体力活动与久坐时间平衡指数"(PASTBI),这是一种潜在的风险识别工具,可用于识别体力活动与久坐行为之间的相互作用;本研究还旨在探讨该指数与澳大利亚成年人全因死亡风险之间的关系:这项前瞻性队列研究分析了澳大利亚糖尿病、肥胖症和生活方式研究(AusDiab)中 5836 名澳大利亚成年人的数据。PASTBI的计算方法是将中度-剧烈活动的总持续时间(分钟/天)除以久坐时间(小时/天),两者均为基线(2004-05年)时的自我报告。PASTBI 以四分位数表示,从 Q1 - 低 PA/高 ST 到 Q4 - 高 PA/低 ST。在对社会人口统计学、生活方式因素、腰围和合并症数量进行调整后,使用 Cox 比例危险回归模型探讨了 PASTBI 与全因死亡率之间的关系(2022 年):在 78 406 人年的随访期间(中位数随访 14.3 年),共有 885 人死亡(15%)。在完全调整模型中,与PASTBI最高的参与者(四分位数4--高PA/低ST)相比,PASTBI最低的参与者(四分位数1--低PA/高ST)的全因死亡风险更高[HR (95% CI) = 1.47 (1.21-1.79)]:结论:PA 和 ST 所花费时间的平衡性较差(根据 PASTBI 指数方法)与较高的全因死亡风险有关。
{"title":"A Physical Activity and Sitting Time Balance Index and All-Cause Mortality Risk.","authors":"Roslin Botlero, Parneet Sethi, Danijela Gasevic, Neville Owen, Elizabeth Barr, David W Dunstan","doi":"10.1016/j.amepre.2024.07.015","DOIUrl":"10.1016/j.amepre.2024.07.015","url":null,"abstract":"<p><strong>Introduction: </strong>Achieving a healthier balance of more time spent in physical activity (PA) and less time in sedentary behavior is now widely advocated for achieving multiple health benefits. This study introduces a Physical Activity and Sitting Time Balance Index (PASTBI), a potential risk identification tool addressing the interplay between PA and sedentary behavior; and aims to explore its association with the risk of all-cause mortality in Australian adults.</p><p><strong>Methods: </strong>This prospective cohort study analyzed the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) data on 5,836 Australian adults. The PASTBI was calculated by dividing the total duration of PA (minutes/day) by the duration of sitting time (ST) (hours/day), both self-reported at baseline (2004-2005). The PASTBI was expressed in quartiles ranging from Q1 - low PA/high ST to Q4 - high PA/low ST. The association between PASTBI and all-cause mortality was explored (in 2022) using the Cox proportional hazards regression models adjusted for socio-demographics, lifestyle factors, waist circumference, and the number of comorbidities.</p><p><strong>Results: </strong>During 78,406 person-years of follow-up (median follow-up of 14.3 years), there were 885 deaths (15%). In the fully adjusted model, compared to those in the highest PASTBI category (Quartile 4 - high PA/low ST), participants from the lowest PASTBI category (Quartile 1 - low PA/high ST) were at a higher risk of all-cause mortality [HR (95% CI) = 1.47 (1.21-1.79)].</p><p><strong>Conclusions: </strong>A less favorable balance of time spent in PA and ST (as characterized by a parsimonious PASTBI index approach) was associated with a higher risk of all-cause mortality.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cost-Effectiveness of Social Determinants of Health Interventions: Evaluating Multisector Community Partnerships' Efforts. 健康干预的社会决定因素的成本效益:评估多部门社区合作伙伴的努力。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-23 DOI: 10.1016/j.amepre.2024.07.016
Amanda A Honeycutt, Olga A Khavjou, Zohra Tayebali, Matthew Dempsey, LaShawn Glasgow, Karen Hacker

Introduction: The purpose of this analysis was to rapidly evaluate the potential costs, cost-effectiveness, and long-term effects of efforts by multisector community partnerships (MCPs) to improve chronic disease outcomes and advance health equity by addressing social determinants of health (SDOH).

Methods: In 2022, the evaluators partnered with 13 MCPs to collect data on start-up and ongoing costs for implementing SDOH interventions and on intervention reach and timing. In 2023, the team used the Prevention Impacts Simulation Model to estimate the longer-term impact of MCPs' efforts over 5-, 10-, and 20-year periods. The team also analyzed costs and cumulative 10- and 20-year cost-effectiveness of the MCPs' SDOH interventions.

Results: Over 20 years, SDOH interventions implemented by the 13 MCPs can potentially prevent 970 premature deaths and avert $105 million in medical costs and $408 million in productivity losses. The 20-year cumulative results show potential net costs of $38,300 per quality-adjusted life-year gained from the healthcare sector perspective and indicate potentially reduced costs and improved health outcomes from the societal perspective.

Conclusions: These findings can help inform and provide support for future investments in SDOH interventions. With a better understanding of costs needed to start up and implement SDOH interventions, funders, and MCPs can prepare for the resources required to do this work. Findings also suggest promising long-term impacts and potential cost-effectiveness for most MCP-implemented SDOH interventions.

导言:这项分析的目的是快速评估多部门社区伙伴关系(MCPs)通过解决健康的社会决定因素(SDOH)来改善慢性病治疗效果和促进健康公平的潜在成本、成本效益和长期效果:2022 年,评估人员与 13 个 MCP 合作,收集有关实施 SDOH 干预措施的启动和持续成本以及干预措施的覆盖范围和时间的数据。2023 年,评估小组利用预防影响模拟模型(PRISM)估算了多边协商进程在 5 年、10 年和 20 年期间所做努力的长期影响。研究小组还分析了多中心 SDOH 干预措施的成本以及 10 年和 20 年的累积成本效益:结果:在 20 年的时间里,13 个多边协商进程实施的 SDOH 干预措施有可能防止 970 人过早死亡,避免 1.05 亿美元的医疗成本和 4.08 亿美元的生产力损失。20 年的累积结果显示,从医疗保健部门的角度来看,每获得一个质量调整生命年的潜在净成本为 38 300 美元,从社会角度来看,可能会降低成本并改善健康状况:这些发现有助于为今后投资 SDOH 干预措施提供信息和支持。通过更好地了解启动和实施 SDOH 干预措施所需的成本,资助者和多边协商进程可以为开展这项工作所需的资源做好准备。研究结果还表明,大多数由多边协商进程实施的 SDOH 干预措施具有良好的长期影响和潜在的成本效益。
{"title":"Cost-Effectiveness of Social Determinants of Health Interventions: Evaluating Multisector Community Partnerships' Efforts.","authors":"Amanda A Honeycutt, Olga A Khavjou, Zohra Tayebali, Matthew Dempsey, LaShawn Glasgow, Karen Hacker","doi":"10.1016/j.amepre.2024.07.016","DOIUrl":"10.1016/j.amepre.2024.07.016","url":null,"abstract":"<p><strong>Introduction: </strong>The purpose of this analysis was to rapidly evaluate the potential costs, cost-effectiveness, and long-term effects of efforts by multisector community partnerships (MCPs) to improve chronic disease outcomes and advance health equity by addressing social determinants of health (SDOH).</p><p><strong>Methods: </strong>In 2022, the evaluators partnered with 13 MCPs to collect data on start-up and ongoing costs for implementing SDOH interventions and on intervention reach and timing. In 2023, the team used the Prevention Impacts Simulation Model to estimate the longer-term impact of MCPs' efforts over 5-, 10-, and 20-year periods. The team also analyzed costs and cumulative 10- and 20-year cost-effectiveness of the MCPs' SDOH interventions.</p><p><strong>Results: </strong>Over 20 years, SDOH interventions implemented by the 13 MCPs can potentially prevent 970 premature deaths and avert $105 million in medical costs and $408 million in productivity losses. The 20-year cumulative results show potential net costs of $38,300 per quality-adjusted life-year gained from the healthcare sector perspective and indicate potentially reduced costs and improved health outcomes from the societal perspective.</p><p><strong>Conclusions: </strong>These findings can help inform and provide support for future investments in SDOH interventions. With a better understanding of costs needed to start up and implement SDOH interventions, funders, and MCPs can prepare for the resources required to do this work. Findings also suggest promising long-term impacts and potential cost-effectiveness for most MCP-implemented SDOH interventions.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762429","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Concealed Handgun License Laws and Concealed Handgun License Adoption, 2002-2019. 2002-2019 年隐蔽式手枪执照法律和隐蔽式手枪执照采用情况。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-20 DOI: 10.1016/j.amepre.2024.07.009
Susan T Parker

Introduction: National-level data suggest that gun owners in the U.S. carry concealed weapons in public at growing rates. This research investigates whether these trends are associated with state adoption of more permissive concealed carry-licensing laws between 2002 and 2019.

Methods: Data were obtained from 31 U.S. states from 2002 to 2019. State-level rates of licenses issued, denied, and newly issued per 100,000 residents were calculated and compared across 3 state legal categories: (1) states that banned carrying-concealed weapons and adopted a shall-issue law, (2) states with a may-issue law that adopted a shall-issue law, and (3) states that made no changes to concealed carry-licensing laws. Difference-in-differences methods were used to compare the rate of licenses newly issued and denied in ban to shall-issue states relative to those in states with no concealed carry-licensing law change during the study timeframe. Data were analyzed in 2022-2023.

Results: States that transitioned from a ban on concealed weapons carrying to shall-issue laws were positively associated (2%-6%, SE=0.11-0.13) with additional new licenses relative to states that did not enact concealed carry-licensing law changes. Ban to shall-issue law changes were also associated with denial of substantially more licenses (75%-85%, SE=0.24-0.23). Furthermore, states that transitioned from may-issue to shall-issue laws awarded fewer licenses than those transitioning from a concealed weapons ban to shall-issue laws.

Conclusions: State-level concealed carry licensing may inform public health and safety policies as large restrictive U.S. states transition to more permissive concealed carry-licensing laws.

导言:国家层面的数据表明,美国持枪者在公共场合隐蔽携带武器的比例越来越高。本研究调查了这些趋势是否与各州在 2002-2019 年间采用更宽容的隐蔽携带许可法有关:从美国 31 个州获得了 2002-2019 年间的数据。计算并比较了三个州法律类别中每 100,000 名居民的州级许可证发放率、拒绝率和新发放率:1)禁止携带隐蔽武器并通过了 "必须颁发 "法律的州;2)拥有 "可以颁发 "法律并通过了 "必须颁发 "法律的州;3)未对隐蔽携带许可证法律进行修改的州。研究采用差分法比较了在研究时间范围内,禁止签发许可证的州与禁止签发许可证的州新签发和拒绝签发许可证的比率,以及没有修改隐蔽携带许可证法律的州新签发和拒绝签发许可证的比率。对 2022-23 年的数据进行了分析:结果:与未颁布隐蔽携带许可证法律变化的州相比,从禁止隐蔽携带武器过渡到应签发法律的州与新增许可证数量呈正相关(2-6%,SE=.11-.13)。从禁止到必须签发法律的变化也与更多许可证被拒绝有关(75-85%,SE=.24-.23)。此外,从可签发法过渡到必须签发法的州比从禁止携带隐蔽武器过渡到必须签发法的州颁发的执照要少:结论:随着美国限制性较大的州向更为宽松的隐蔽持枪许可法律过渡,州一级的隐蔽持枪许可可为公共健康和安全政策提供参考。
{"title":"Concealed Handgun License Laws and Concealed Handgun License Adoption, 2002-2019.","authors":"Susan T Parker","doi":"10.1016/j.amepre.2024.07.009","DOIUrl":"10.1016/j.amepre.2024.07.009","url":null,"abstract":"<p><strong>Introduction: </strong>National-level data suggest that gun owners in the U.S. carry concealed weapons in public at growing rates. This research investigates whether these trends are associated with state adoption of more permissive concealed carry-licensing laws between 2002 and 2019.</p><p><strong>Methods: </strong>Data were obtained from 31 U.S. states from 2002 to 2019. State-level rates of licenses issued, denied, and newly issued per 100,000 residents were calculated and compared across 3 state legal categories: (1) states that banned carrying-concealed weapons and adopted a shall-issue law, (2) states with a may-issue law that adopted a shall-issue law, and (3) states that made no changes to concealed carry-licensing laws. Difference-in-differences methods were used to compare the rate of licenses newly issued and denied in ban to shall-issue states relative to those in states with no concealed carry-licensing law change during the study timeframe. Data were analyzed in 2022-2023.</p><p><strong>Results: </strong>States that transitioned from a ban on concealed weapons carrying to shall-issue laws were positively associated (2%-6%, SE=0.11-0.13) with additional new licenses relative to states that did not enact concealed carry-licensing law changes. Ban to shall-issue law changes were also associated with denial of substantially more licenses (75%-85%, SE=0.24-0.23). Furthermore, states that transitioned from may-issue to shall-issue laws awarded fewer licenses than those transitioning from a concealed weapons ban to shall-issue laws.</p><p><strong>Conclusions: </strong>State-level concealed carry licensing may inform public health and safety policies as large restrictive U.S. states transition to more permissive concealed carry-licensing laws.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735635","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Co-Vaping of Nicotine and Cannabis by Sexual Identity Among US Adults: Results From the 2022 National Survey on Drug Use and Health. 美国成年人按性别特征划分的尼古丁和大麻共同吸食情况:2022 年全国毒品使用和健康调查的结果。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-19 DOI: 10.1016/j.amepre.2024.07.011
Juhan Lee, Daniel P Giovenco
{"title":"Co-Vaping of Nicotine and Cannabis by Sexual Identity Among US Adults: Results From the 2022 National Survey on Drug Use and Health.","authors":"Juhan Lee, Daniel P Giovenco","doi":"10.1016/j.amepre.2024.07.011","DOIUrl":"10.1016/j.amepre.2024.07.011","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Examining the 2021 Cash Value Benefit Increase and WIC Participant Food Purchases. 研究 2021 年现金价值福利增长和 WIC 参与者的食品购买量。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-19 DOI: 10.1016/j.amepre.2024.07.013
Emily W Duffy, Shu Wen Ng, Maxime Bercholz, Cassandra R Davis, Molly De Marco, Marissa G Hall, Joanna Maselko, Lindsey Smith Taillie

Introduction: The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) provides nutritious foods to more than six million low-income families. In June 2021, WIC increased the amount of money provided for fruits and vegetables (FV), but studies have not investigated whether this increase changed WIC participant FV purchases. The objective was to estimate the association between the FV funding increase and WIC shopper FV purchases.

Methods: This evaluation uses longitudinal food transaction data from 496 stores in a grocery store chain in North Carolina between June 2020 and April 2022 and a propensity score weighted difference-in-differences (DID) approach to estimate the association between the FV funding increase and FV and other food group purchases. Analyses were conducted in 2023 and 2024.

Results: WIC shoppers' WIC-eligible FV purchases increased by $12.4 per shopper per month (adjusted confidence interval [ACI], $12.0-$12.9) after the FV benefit increase, which was $9.3 (ACI, $8.7-$10.0) more than non-WIC shoppers. The monthly volume and unique varieties of FV purchased also increased more among WIC shoppers relative to non-WIC shoppers (DID 67.1 ounces [ACI, 61.9-72.3] and DID 2.1 varieties [ACI, 2.0-2.3]). There were also increases in the volume of processed foods (DID 22.0 ounces [ACI, 17.2, 26.9]) and sugar-sweetened beverages (DID 49.1 ounces [ACI, 33.4, 64.9]) purchased among WIC shoppers relative to non-WIC shoppers.

Conclusions: Increased WIC FV funding was associated with greater FV purchases. Research is needed to understand the effects of this policy on total dietary intake.

导言:妇女、婴儿和儿童特别补充营养计划(WIC)为 600 多万低收入家庭提供营养食品。2021 年 6 月,妇女、婴儿和儿童特殊补充营养计划增加了对水果和蔬菜(FV)的资助金额,但尚未有研究调查这一增加是否改变了妇女、婴儿和儿童特殊补充营养计划参与者的 FV 购买量。我们的目标是估算果蔬资金的增加与 WIC 购物者果蔬购买量之间的关联:本评估使用了 2020 年 6 月至 2022 年 4 月期间北卡罗来纳州一家连锁杂货店 496 家商店的纵向食品交易数据,并采用倾向得分加权差分法(DID)估算了食品添加剂供资增长与食品添加剂及其他食品类别购买之间的关联。分析在 2023 年和 2024 年进行:在增加食品添加剂补贴后,WIC 购物者每人每月符合 WIC 标准的食品添加剂购买量增加了 12.4 美元(调整置信区间为 12.0 美元至 12.9 美元),比非 WIC 购物者多 9.3 美元(调整置信区间为 8.7 美元至 10.0 美元)。与非 WIC 购物者相比,WIC 购物者每月购买的食品添加剂数量和独特品种也有所增加(DID 为 67.1 盎司(ACI 为 61.9 至 72.3),DID 为 2.1 个品种(ACI 为 2.0 至 2.3))。与非 WIC 购物者相比,WIC 购物者购买的加工食品(DID 22.0 盎司(ACI,17.2,26.9))和含糖饮料(DID 49.1 盎司(ACI,33.4,64.9))的数量也有所增加:结论:WIC 食品添加剂资助的增加与食品添加剂购买量的增加有关。要了解这项政策对膳食总摄入量的影响,还需要进行研究。
{"title":"Examining the 2021 Cash Value Benefit Increase and WIC Participant Food Purchases.","authors":"Emily W Duffy, Shu Wen Ng, Maxime Bercholz, Cassandra R Davis, Molly De Marco, Marissa G Hall, Joanna Maselko, Lindsey Smith Taillie","doi":"10.1016/j.amepre.2024.07.013","DOIUrl":"10.1016/j.amepre.2024.07.013","url":null,"abstract":"<p><strong>Introduction: </strong>The Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) provides nutritious foods to more than six million low-income families. In June 2021, WIC increased the amount of money provided for fruits and vegetables (FV), but studies have not investigated whether this increase changed WIC participant FV purchases. The objective was to estimate the association between the FV funding increase and WIC shopper FV purchases.</p><p><strong>Methods: </strong>This evaluation uses longitudinal food transaction data from 496 stores in a grocery store chain in North Carolina between June 2020 and April 2022 and a propensity score weighted difference-in-differences (DID) approach to estimate the association between the FV funding increase and FV and other food group purchases. Analyses were conducted in 2023 and 2024.</p><p><strong>Results: </strong>WIC shoppers' WIC-eligible FV purchases increased by $12.4 per shopper per month (adjusted confidence interval [ACI], $12.0-$12.9) after the FV benefit increase, which was $9.3 (ACI, $8.7-$10.0) more than non-WIC shoppers. The monthly volume and unique varieties of FV purchased also increased more among WIC shoppers relative to non-WIC shoppers (DID 67.1 ounces [ACI, 61.9-72.3] and DID 2.1 varieties [ACI, 2.0-2.3]). There were also increases in the volume of processed foods (DID 22.0 ounces [ACI, 17.2, 26.9]) and sugar-sweetened beverages (DID 49.1 ounces [ACI, 33.4, 64.9]) purchased among WIC shoppers relative to non-WIC shoppers.</p><p><strong>Conclusions: </strong>Increased WIC FV funding was associated with greater FV purchases. Research is needed to understand the effects of this policy on total dietary intake.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735637","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Author Reply to Letter to the Editor Regarding “Accuracy of Online Artificial Intelligence Models in Primary Care Settings” 作者就 "在线人工智能模型在基层医疗机构中的准确性 "致编辑的回信
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-18 DOI: 10.1016/j.amepre.2024.03.016
{"title":"Author Reply to Letter to the Editor Regarding “Accuracy of Online Artificial Intelligence Models in Primary Care Settings”","authors":"","doi":"10.1016/j.amepre.2024.03.016","DOIUrl":"10.1016/j.amepre.2024.03.016","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141638624","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ACPM Member Spotlight—Eric Deussing, MD, MPH, FACPM ACPM 会员聚焦-Eric Deussing,医学博士,公共卫生硕士,FACPM
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-18 DOI: 10.1016/j.amepre.2024.04.005
{"title":"ACPM Member Spotlight—Eric Deussing, MD, MPH, FACPM","authors":"","doi":"10.1016/j.amepre.2024.04.005","DOIUrl":"10.1016/j.amepre.2024.04.005","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141638625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Change in Cardiorespiratory Fitness and Risk of Depression, Anxiety, and Cerebrovascular Disease. 心肺功能的变化与抑郁、焦虑和脑血管疾病的风险。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-18 DOI: 10.1016/j.amepre.2024.07.012
Camilla A Wiklund, Magnus Lindwall, Örjan Ekblom, Jenny Nyberg, Maria I Åberg, Sofia Paulsson, Elin Ekblom-Bak

Introduction: High cardiorespiratory fitness (CRF) has been associated with a lower risk of depression, anxiety, and cerebrovascular disease. The aim was to explore CRF changes over-time associated with these outcomes.

Methods: This large-scale prospective cohort study, using data from Swedish population-wide registries and databases (during 1972-2020), included men (n=131,431), with measures of estimated CRF (estCRF) in late adolescence (maximal cycle test) and adulthood (submaximal cycle test) (mean years between 24.6, SD 8.8). The study explored how change in estCRF was associated with incident depression, anxiety, and cerebrovascular disease using Cox proportional hazards models. Analyses were performed in 2023.

Results: Higher estCRF in late adolescence and adulthood were associated with a lower risk of incident depression, anxiety, and cerebrovascular disease later in life. For all three outcomes, an increase in estCRF (mL/min/kg and z-score) between the two-time points was associated with a lower risk. Further, decreasing from moderate or high estCRF in adolescence to low estCRF in adulthood, compared to staying at a moderate or high level, was associated with a higher risk of depression and anxiety (HR: 1.24 95% CI 1.07-1.45 and 1.25 95% CI 1.06-1.49, respectively). Conversely, increasing from moderate to high estCRF was associated with a lower risk of incident anxiety (HR: 0.84 95% CI 0.71-0.99).

Conclusions: The findings indicate that there is a longitudinal association between negative change in estCRF and increased risk of depression, anxiety, and cerebrovascular disease later in life. Decreasing levels of estCRF could be a helpful indicator when identifying these disorders at a population level.

简介高心肺功能(CRF)与较低的抑郁、焦虑和脑血管疾病风险有关。本研究旨在探讨心肺功能随时间的变化与这些结果的关系:这项大规模前瞻性队列研究使用了瑞典全人口登记和数据库(1972-2020 年)中的数据,研究对象包括男性(131,431 人),他们在青春期后期(最大循环测试)和成年期(次最大循环测试)(平均年龄介于 24.6 岁和 SD 8.8 岁之间)对估计的 CRF(estCRF)进行了测量。该研究使用 Cox 比例危险模型探讨了 estCRF 的变化与抑郁症、焦虑症和脑血管疾病的发生之间的关系。分析于 2023 年进行:结果:青春期后期和成年期雌激素受体水平越高,日后患抑郁症、焦虑症和脑血管疾病的风险越低。在所有三种结果中,两个时间点之间estCRF(毫升/分钟/千克和z-分数)的增加与风险降低有关。此外,与保持在中度或高度水平相比,青春期estCRF从中度或高度下降到成年期的低estCRF与抑郁和焦虑的较高风险有关(HR:分别为1.24 95%CI 1.07-1.45和1.25 95%CI 1.06-1.49)。相反,estCRF 从中度升至高度与较低的焦虑事件风险相关(HR:0.84 95%CI 0.71-0.99):研究结果表明,雌激素转换因子的负向变化与日后抑郁、焦虑和脑血管疾病风险的增加之间存在纵向联系。estCRF水平的下降可能是在人群中识别这些疾病的一个有用指标。
{"title":"Change in Cardiorespiratory Fitness and Risk of Depression, Anxiety, and Cerebrovascular Disease.","authors":"Camilla A Wiklund, Magnus Lindwall, Örjan Ekblom, Jenny Nyberg, Maria I Åberg, Sofia Paulsson, Elin Ekblom-Bak","doi":"10.1016/j.amepre.2024.07.012","DOIUrl":"10.1016/j.amepre.2024.07.012","url":null,"abstract":"<p><strong>Introduction: </strong>High cardiorespiratory fitness (CRF) has been associated with a lower risk of depression, anxiety, and cerebrovascular disease. The aim was to explore CRF changes over-time associated with these outcomes.</p><p><strong>Methods: </strong>This large-scale prospective cohort study, using data from Swedish population-wide registries and databases (during 1972-2020), included men (n=131,431), with measures of estimated CRF (estCRF) in late adolescence (maximal cycle test) and adulthood (submaximal cycle test) (mean years between 24.6, SD 8.8). The study explored how change in estCRF was associated with incident depression, anxiety, and cerebrovascular disease using Cox proportional hazards models. Analyses were performed in 2023.</p><p><strong>Results: </strong>Higher estCRF in late adolescence and adulthood were associated with a lower risk of incident depression, anxiety, and cerebrovascular disease later in life. For all three outcomes, an increase in estCRF (mL/min/kg and z-score) between the two-time points was associated with a lower risk. Further, decreasing from moderate or high estCRF in adolescence to low estCRF in adulthood, compared to staying at a moderate or high level, was associated with a higher risk of depression and anxiety (HR: 1.24 95% CI 1.07-1.45 and 1.25 95% CI 1.06-1.49, respectively). Conversely, increasing from moderate to high estCRF was associated with a lower risk of incident anxiety (HR: 0.84 95% CI 0.71-0.99).</p><p><strong>Conclusions: </strong>The findings indicate that there is a longitudinal association between negative change in estCRF and increased risk of depression, anxiety, and cerebrovascular disease later in life. Decreasing levels of estCRF could be a helpful indicator when identifying these disorders at a population level.</p>","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141735634","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Letter to the Editor Regarding “Accuracy of Online Artificial Intelligence Models in Primary Care Settings” 致编辑的信,内容涉及 "在线人工智能模型在基层医疗机构中的准确性"。
IF 4.3 2区 医学 Q1 MEDICINE, GENERAL & INTERNAL Pub Date : 2024-07-18 DOI: 10.1016/j.amepre.2024.03.017
{"title":"Letter to the Editor Regarding “Accuracy of Online Artificial Intelligence Models in Primary Care Settings”","authors":"","doi":"10.1016/j.amepre.2024.03.017","DOIUrl":"10.1016/j.amepre.2024.03.017","url":null,"abstract":"","PeriodicalId":50805,"journal":{"name":"American Journal of Preventive Medicine","volume":null,"pages":null},"PeriodicalIF":4.3,"publicationDate":"2024-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141638623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
American Journal of Preventive Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1